Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2018 Publisher: iNova Pharmaceuticals (New Zealand) Limited, c/- Simpson Grierson, 88 Shortland Street, Auckland 1141
ACUPAN 30 mg tablets.
| Pharmaceutical Form |
|---|
|
White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face. |
Each tablet contains nefopam hydrochloride 30 mg.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nefopam |
|
| List of Excipients |
|---|
|
Calcium hydrogen phosphate dihydrate The tablet formulation is colour-free, preservative-free, sugar-free, and does not contain gluten or lactose. |
Blister foil packs of 90 tablets.
iNova Pharmaceuticals (New Zealand) Limited, c/- Simpson Grierson, 88 Shortland Street, Auckland 1141
15 May 1980
| Drug | Countries | |
|---|---|---|
| ACUPAN | France, New Zealand, Romania, Tunisia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
